News Drugs could mimic gut bacteria benefits to treat diabetes It may be possible to design drugs that mimic the positive health benefits of gut bacteria to treat diseases such as type II diabetes, a new study has found.
Partner Content Partner Content Review Microbiome Start-Up Success Stories & Business Models Your Invite - Microbiome Start-Up Focus Evening
Partner Content Partner Content Regulatory Guidance for Microbiome-Based Therapeutics Join The Microbiome Movement
Partner Content Partner Content An Interview with Chris Damman, Bill & Melinda Gates Foundat... The Microbiome Movement recently had the delight of interviewing Chris Damman from the Bill & Melinda Gates Foundation and discussed his career, resea
Partner Content Partner Content Personal Highlights – Microbiome Movement – Maternal & I... Discovering The Maternal-Infant Microbiome
Partner Content Partner Content 5 Leaders, 1 Panel: Microbiome Movement - Drug Development S... 5 Leaders, 1 Panel: Join The Microbiome Movement
News Novo Nordisk preps filings for sickle cell drug etavopivat Novo Nordisk has claimed a key win in its head-to-head race with Agios to bring an oral PKR activator to the market for sickle cell disease.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.